These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 1479676)

  • 1. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs].
    Matsuo K; Uete T
    Jpn J Antibiot; 1993 Feb; 46(2):130-41. PubMed ID: 8331773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical laboratory approach to evaluate administration dose of arbekacin. Reevaluation of in vitro MIC break points in the disk susceptibility test].
    Matsuo K; Uete T
    Jpn J Antibiot; 1994 Aug; 47(8):1041-52. PubMed ID: 7933533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system].
    Matsuo K; Uete T
    Jpn J Antibiot; 1989 Nov; 42(11):2377-92. PubMed ID: 2621780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam in combination against methicillin-susceptible and -resistant Staphylococcus aureus studied using checkerboard MIC method and disc diffusion method with discs containing both drugs].
    Matsuo K; Uete T
    Jpn J Antibiot; 1993 Mar; 46(3):222-33. PubMed ID: 8510319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical laboratory approach to estimate effective administrative dose of minocyclin. Reevaluation of in vitro MIC break points in disc susceptibility test].
    Uete G; Matsuo K; Uete T
    Jpn J Antibiot; 1990 Sep; 43(9):1545-58. PubMed ID: 2262962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical laboratory approach to evaluate efficacy of amikacin. Reevaluation of in vitro MIC break points in disc susceptibility test].
    Uete G; Matsuo K; Uete T
    Jpn J Antibiot; 1992 May; 45(5):489-501. PubMed ID: 1512934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002].
    Abe T; Sato Y; Sei M
    Jpn J Antibiot; 2003 Dec; 56(6):574-83. PubMed ID: 15007873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical laboratory approach for estimating the effective administrative dose of latamoxef. Significance of a 4-category system interpretation of the latamoxef disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1987 Nov; 40(11):1906-16. PubMed ID: 3327966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibilities of uropathogenic bacteria to ampicillin, cefazolin, cefmetazole and gentamicin. Nine-year survey of changing patterns of susceptibilities].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1990 Sep; 43(9):1530-7. PubMed ID: 2262960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical laboratory approach in estimating the effective dosage of cefamandole].
    Uete G; Matsuo K; Uete T
    Jpn J Antibiot; 1988 Jun; 41(6):631-40. PubMed ID: 3221428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical laboratory approach in estimating effective administrative dose of piperacillin. Reevaluation of MIC break points in 3 and 4 category systems of disc susceptibility test].
    Matsuo K; Uete T
    Jpn J Antibiot; 1990 Sep; 43(9):1559-71. PubMed ID: 2262963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical laboratory approach for estimating effective administrative dose of cephalothin. Reevaluation of MIC break points in 4 category system of disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1989 Sep; 42(9):1900-12. PubMed ID: 2810753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro synergism of two-drug combinations among cefamandole, flomoxef and imipenem against MRSA].
    Inoue M; Sakurai N; Matsui H; Tsunoda M; Okubo T
    Jpn J Antibiot; 1990 Feb; 43(2):233-8. PubMed ID: 2362351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
    Uete T; Matsuo K
    Jpn J Antibiot; 1988 Nov; 41(11):1578-90. PubMed ID: 3210296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical laboratory approach for estimating effective administrative dose of ceftizoxime. Observation from MIC and ceftizoxime disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1987 Feb; 40(2):331-9. PubMed ID: 3474430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.